Juliana Gomez Abanto, MD
Neurology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Upson Medical Associates LLC · St. Joseph Hospital of Nashua Nh
Looking this up.
Hospitals listed: Chi Health Lakeside · HCA Florida Putnam Hospital · HCA Florida St Lucie Hospital · Mcleod Loris Hospital · Winter Haven Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abanto’s office to ask if they take your plan before you enroll.
State licence records
2 licences
- Florida ME170254Medical Doctor · since 2024 · expires 2027-01-31Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
- Texas T2171Physician License · since 2021 · expires 2027-08-31Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Universidad Privada Antenor Orrego2002–2009
Residency and fellowship
- McGovern Medical School at UTHealth, OTHERHouston, TX · 2020–2021
- Texas Tech University Health Sciences Center, NEUROLOGYLubbock, TX · 2016–2020
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Out of State
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Colorado · New York · Texas
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chi Health LakesideOmaha, NEAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.253, Oct 2024 – Sep 2025
- HCA Florida Putnam HospitalPalatka, FLAcute Care Hospital · Proprietary · Has an emergency departmentPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 3 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.111, Oct 2024 – Sep 2025
- Mcleod Loris HospitalLoris, SCAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of McLeod Health, which runs 6 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.083, Oct 2024 – Sep 2025
- St Lucie Medical CenterPort Saint Lucie, FLAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.7) · 453 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Winter Haven HospitalWinter Haven, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.337, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.141, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.1, Oct 2024 – Sep 2025
See every measure and the patient survey for Chi Health Lakeside
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 724 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.48 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 159.97 (105.08 to 214.87) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 167 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 266 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 166 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,821 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,648 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 3,592 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.09 (1.83 to 6.36) · 703 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.1 (0.46 to 3.75) · 649 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.32 (0 to 16.67) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (1.22 to 9.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.04) · 2,960 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 61 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.321 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.138 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 145 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 359 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18.2 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6.6 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11 · 159 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 223 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9 to 15.7) · 769 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 500 cases | No different | Jan 2024 – Dec 2024 |
What patients said (522 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 3 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for HCA Florida Putnam Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.111 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 171 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.55 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.2 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.9 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 20.9 · 244 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.7 · 75 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,286 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,661 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,608 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.96 (1.49 to 6.43) · 348 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.21 (0.52 to 3.89) · 330 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.94 (1.35 to 20.53) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.91 (1.67 to 10.15) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.24) · 2,006 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 37 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 150 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 418 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.1 · 287 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.5 · 250 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 363 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 262 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.2) · 162 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 39 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 17% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
See every measure and the patient survey for Mcleod Loris Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.083 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.22 (0.28 to 2.16) · 1,277 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.78 (0.46 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.62 (125.32 to 237.91) · 64 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.6 · 230 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.7 · 657 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 651 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 265 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 4,264 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 7,341 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.44) · 7,237 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.4 (0.36 to 4.45) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.75 (0.21 to 3.3) · 552 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.9 (0.44 to 3.37) · 1,500 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.36 (0 to 12.06) · 640 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.84 (2.41 to 9.28) · 549 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.12 to 3.01) · 392 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.06) · 5,797 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 134 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.213 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.375 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.309 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.898 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 294 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.8 · 904 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.7 · 175 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.3 · 697 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 15.2 · 631 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 770 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 350 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.3 (10.6 to 16.7) · 2,787 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 1,826 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,010 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 64% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for St Lucie Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 1 the same, 6 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.7) · 453 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.9) · 853 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.51 to 1.21) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 148.47 (91.17 to 205.77) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 380 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.8 · 141 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,509 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.01 to 0.42) · 6,994 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.05 to 0.44) · 6,989 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.49 (0.41 to 4.57) · 1,574 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 799 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.12 to 4.22) · 1,531 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.61 (2.86 to 18.35) · 851 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.64 (1.78 to 9.5) · 792 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 239 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 5,122 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 308 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.478 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.281 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 164 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.1 · 738 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 31.1 · 101 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.4 · 444 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.1 · 527 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 826 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.1 to 8.1) · 27 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.4 to 15.2) · 27 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 8.7 · 235 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 327 cases | None | Jul 2023 – Jun 2025 |
What patients said (613 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 69% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for Winter Haven Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.141 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.1 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.12 to 2.11) · 965 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.74 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 136.21 (90.73 to 181.69) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 12.2 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 173 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 397 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 21.5 · 516 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 4,906 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,214 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.62 (0.49 to 4.75) · 1,160 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 324 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.68 (1.2 to 4.16) · 1,135 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.44 (2.03 to 14.85) · 351 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.3 (2.47 to 10.14) · 320 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.96 (0.27 to 1.65) · 5,443 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.43 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.783 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 441 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 1,066 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 26.8 · 203 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.3 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 19.6 · 530 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 1,101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.3) · 75 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.3 to 14.4) · 75 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.3 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 23 · 479 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.3 to 16.5) · 452 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 386 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,279 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$45,215
Medicare paid this office $45,215 for 258 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 76 | $8,696 | $94 |
| New patient visit (60+ min) | 51 | $7,467 | $146 |
| Long return visit (40+ min) | 41 | $5,868 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $5,788 | $135 |
| Short return visit (20+ min) | 54 | $3,443 | $61 |
See all 8 services
| Return visit (30+ min) | 76 | $8,696 | $94 |
| New patient visit (60+ min) | 51 | $7,467 | $146 |
| Long return visit (40+ min) | 41 | $5,868 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $5,788 | $135 |
| Short return visit (20+ min) | 54 | $3,443 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,673 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,579 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,535 | $96 |
Who their Medicare patients are
258 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 10% · Women 54% · Also on Medicaid 32% · Health risk score 1.61. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 42% · Depression 40% · Diabetes 37% · Chronic kidney disease 28% · COPD 25% · Coronary heart disease 23% · Atrial fibrillation 22% · Heart failure 20% · Dementia 17% · Cancer 13%.
The office billed $114,890, Medicare allowed $61,721 and paid $45,215; for 706 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 258 | 706 | 72 | 1.61 | $114,890 | $45,215 |
| 2023 | 222 | 383 | 71 | 1.61 | $83,216 | $39,131 |
| 2022 | 236 | 405 | 70 | 1.84 | $88,297 | $43,942 |
| 2021 | 111 | 177 | 70 | 1.47 | $37,193 | $20,308 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 58 | $10,432 | $137 |
| Return visit (30+ min) | 76 | $7,278 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $6,374 | $136 |
| New patient visit (60+ min) | 41 | $5,382 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,374 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,102 | $96 |
| Short return visit (20+ min) | 24 | $1,418 | $59 |
2022: 9 services
| New patient visit (60+ min) | 58 | $9,828 | $169 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,516 | $157 |
| Long return visit (40+ min) | 50 | $7,167 | $138 |
| Return visit (30+ min) | 66 | $7,053 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $4,074 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,922 | $57 |
| Short return visit (20+ min) | 22 | $1,692 | $65 |
| New patient visit (45+ min) | 11 | $1,435 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,394 | $107 |
2021: 6 services
| New patient visit (60+ min) | 33 | $5,849 | $177 |
| Long return visit (40+ min) | 28 | $4,331 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,767 | $161 |
| Return visit (30+ min) | 14 | $1,489 | $106 |
| New patient visit (45+ min) | 11 | $1,474 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,326 | $58 |
Medicaid work
$23,049 in 2024
Medicaid paid $23,049 for 303 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 157 | $10,271 |
| New patient visit (60+ min) | 71 | $8,977 |
| Short return visit (20+ min) | 63 | $2,738 |
| Long return visit (40+ min) | 12 | $1,064 |
| 2024 | 303 | 4 | 34 | $23,049 |
| 2023 | 418 | 5 | 42 | $38,364 |
| 2022 | 286 | 3 | 29 | $28,336 |
| 2021 | 102 | 2 | 24 | $14,072 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 135 | $12,177 |
| Return visit (30+ min) | 174 | $11,802 |
| New patient visit (60+ min) | 83 | $11,638 |
| MRI BRAIN BRAIN STEM W/O W/CONTRAST MATERIAL | 12 | $2,747 |
| Injection, gadoterate meglumine, 0.1 ml | 14 | $0 |
2022
| New patient visit (60+ min) | 85 | $12,555 |
| Return visit (30+ min) | 128 | $9,110 |
| Long return visit (40+ min) | 73 | $6,672 |
2021
| New patient visit (60+ min) | 88 | $12,509 |
| New patient visit (45+ min) | 14 | $1,563 |
Drugs they prescribed that Part D paid
$2,749,688
Pharmacies billed $2,749,688 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,638) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
1,841 generic and fewer than 11 brand-name prescriptions · $2,749,688 in drug cost · 45 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Kesimpta | None | 53 | $578,343 | $10,912 |
| Gamunex-C | Immune globulin | 26 | $194,878 | $7,495 |
| Nuplazid | Parkinson's psychosis | 34 | $156,205 | $4,594 |
| Nurtec Odt | None | 91 | $125,369 | $1,378 |
| Vumerity | None | 12 | $120,106 | $10,009 |
See all 56 drugs
| Kesimpta | None | 53 | $578,343 | $10,912 |
| Gamunex-C | Immune globulin | 26 | $194,878 | $7,495 |
| Nuplazid | Parkinson's psychosis | 34 | $156,205 | $4,594 |
| Nurtec Odt | None | 91 | $125,369 | $1,378 |
| Vumerity | None | 12 | $120,106 | $10,009 |
| Emgality | Migraine | 145 | $114,981 | $793 |
| Ingrezza | None | 12 | $97,523 | $8,127 |
| Ubrelvy | None | 65 | $90,986 | $1,400 |
| Aimovig | Migraine | 86 | $70,234 | $817 |
| Nourianz | None | 20 | $56,233 | $2,812 |
| Ajovy | None | 43 | $43,044 | $1,001 |
| Gocovri | None | 12 | $40,712 | $3,393 |
| Glatopa | None | 17 | $40,600 | $2,388 |
| Qulipta | None | 31 | $33,693 | $1,087 |
| Emgality | Migraine | 25 | $30,385 | $1,215 |
| Reyvow | None | 31 | $23,041 | $743 |
| Briviact | None | 14 | $19,877 | $1,420 |
| Glatiramer Acetate | None | 12 | $19,652 | $1,638 |
| Droxidopa | None | 13 | $15,639 | $1,203 |
| Botox | None | 11 | $14,185 | $1,290 |
| Eliquis | None | 16 | $12,465 | $779 |
| Dalfampridine Er | None | 40 | $9,385 | $235 |
| Carbidopa-Levodopa | None | 212 | $7,194 | $34 |
| Primidone | None | 200 | $7,024 | $35 |
| Lacosamide | None | 48 | $3,550 | $74 |
| Amantadine | None | 65 | $3,479 | $54 |
| Topiramate | None | 114 | $3,225 | $28 |
| Carbidopa-Levodopa Er | None | 71 | $3,172 | $45 |
| Levetiracetam | None | 83 | $2,242 | $27 |
| Propranolol Hcl Er | None | 27 | $1,733 | $64 |
| Carbamazepine | None | 17 | $1,460 | $86 |
| Gabapentin | None | 89 | $1,354 | $15 |
| Propranolol | None | 68 | $1,326 | $20 |
| Pyridostigmine | None | 15 | $1,288 | $86 |
| Selegiline | None | 14 | $1,170 | $84 |
| Pregabalin | None | 21 | $1,071 | $51 |
| Lamotrigine | None | 72 | $998 | $14 |
| Rizatriptan | None | 37 | $825 | $22 |
| Memantine | None | 13 | $798 | $61 |
| Pramipexole Dihydrochloride | None | 23 | $721 | $31 |
| Baclofen | None | 59 | $691 | $12 |
| Zonisamide | None | 44 | $669 | $15 |
| Teriflunomide | None | 13 | $593 | $46 |
| Donepezil | None | 62 | $487 | $8 |
| Oxcarbazepine | None | 14 | $485 | $35 |
| Divalproex | None | 19 | $474 | $25 |
| Atorvastatin | None | 36 | $361 | $10 |
| Rosuvastatin | None | 18 | $319 | $18 |
| Ropinirole | None | 22 | $235 | $11 |
| Amitriptyline | None | 24 | $204 | $8 |
| Cyclobenzaprine | None | 20 | $202 | $10 |
| Phenytoin Sodium Extended | None | 14 | $194 | $14 |
| Clopidogrel | None | 30 | $182 | $6 |
| Quetiapine | None | 16 | $135 | $8 |
| Clonazepam | None | 15 | $50 | $3 |
| Metoprolol | None | 17 | $45 | $3 |
Year by year
| 2024 | 2,638 | 326 | 0% (0) | None | $2,749,688 |
| 2023 | 2,163 | 269 | 0% (0) | 29% | $1,882,171 |
| 2022 | 1,137 | 225 | 0% (0) | 22% | $796,046 |
| 2021 | 164 | 69 | 0% (0) | 22% | $199,673 |
| 2020 | 205 | 37 | 0% (0) | None | $55,854 |
| 2019 | 348 | 46 | None | None | $116,193 |
| 2018 | 274 | 37 | 0% (0) | None | $48,811 |
| 2017 | 57 | 12 | 0% (0) | 23% | $5,207 |
| 2016 | 18 | None | 0% (0) | None | $164 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Kesimpta | None | 27 | $297,811 | $11,030 |
| Vumerity | None | 19 | $167,097 | $8,795 |
| Gamunex-C | Immune globulin | 27 | $141,877 | $5,255 |
| Emgality | Migraine | 153 | $138,607 | $906 |
| Ingrezza | None | 16 | $130,638 | $8,165 |
| Aimovig | Migraine | 111 | $97,012 | $874 |
| Nurtec Odt | None | 74 | $84,141 | $1,137 |
| Nuplazid | Parkinson's psychosis | 11 | $47,507 | $4,319 |
| Botox | None | 16 | $31,174 | $1,948 |
| Reyvow | None | 38 | $30,445 | $801 |
| Emgality | Migraine | 19 | $16,072 | $846 |
| Ubrelvy | None | 13 | $13,268 | $1,021 |
| Eliquis | None | 14 | $11,191 | $799 |
| Carbidopa-Levodopa | None | 177 | $10,042 | $57 |
| Dimethyl | None | 19 | $8,594 | $452 |
| Primidone | None | 161 | $6,377 | $40 |
| Lacosamide | None | 26 | $6,286 | $242 |
| Carbidopa-Levodopa Er | None | 37 | $4,288 | $116 |
| Rasagiline Mesylate | None | 15 | $4,106 | $274 |
| Sumatriptan | None | 38 | $3,944 | $104 |
| Pyridostigmine | None | 21 | $3,875 | $185 |
| Dalfampridine Er | None | 28 | $3,430 | $122 |
| Propranolol | None | 58 | $3,033 | $52 |
| Levetiracetam | None | 90 | $2,667 | $30 |
| Amantadine | None | 27 | $2,580 | $96 |
| Topiramate | None | 99 | $2,229 | $23 |
| Selegiline | None | 22 | $2,064 | $94 |
| Propranolol Hcl Er | None | 30 | $1,827 | $61 |
| Baclofen | None | 88 | $1,827 | $21 |
| Carbamazepine | None | 14 | $1,551 | $111 |
| Pramipexole Dihydrochloride | None | 19 | $1,330 | $70 |
| Rizatriptan | None | 40 | $1,328 | $33 |
| Gabapentin | None | 72 | $1,261 | $18 |
| Zonisamide | None | 26 | $906 | $35 |
| Amitriptyline | None | 33 | $870 | $26 |
| Divalproex Sodium Er | None | 11 | $854 | $78 |
| Phenytoin Sodium Extended | None | 19 | $720 | $38 |
| Oxcarbazepine | None | 13 | $602 | $46 |
| Lamotrigine | None | 39 | $530 | $14 |
| Atorvastatin | None | 38 | $511 | $13 |
| Pregabalin | None | 14 | $351 | $25 |
| Clopidogrel | None | 26 | $303 | $12 |
| Donepezil | None | 23 | $276 | $12 |
| Metoprolol | None | 32 | $193 | $6 |
| Duloxetine | None | 13 | $179 | $14 |
| Clonazepam | None | 18 | $82 | $5 |
| Divalproex | None | 12 | $67 | $6 |
| Cyclobenzaprine | None | 11 | $57 | $5 |
| Prednisone | None | 11 | $47 | $4 |
2022: 29 drugs
| Emgality | Migraine | 71 | $72,421 | $1,020 |
| Reyvow | None | 37 | $26,121 | $706 |
| Aimovig | Migraine | 30 | $25,888 | $863 |
| Nurtec Odt | None | 19 | $22,355 | $1,177 |
| Emgality | Migraine | 11 | $12,844 | $1,168 |
| Dimethyl | None | 32 | $8,270 | $258 |
| Carbidopa-Levodopa | None | 86 | $2,921 | $34 |
| Levetiracetam | None | 78 | $2,605 | $33 |
| Primidone | None | 75 | $2,006 | $27 |
| Propranolol | None | 58 | $1,368 | $24 |
| Carbidopa-Levodopa Er | None | 17 | $1,273 | $75 |
| Gabapentin | None | 45 | $1,268 | $28 |
| Topiramate | None | 36 | $1,229 | $34 |
| Amantadine | None | 15 | $1,205 | $80 |
| Baclofen | None | 47 | $1,205 | $26 |
| Pramipexole Dihydrochloride | None | 14 | $795 | $57 |
| Sumatriptan | None | 14 | $586 | $42 |
| Oxcarbazepine | None | 11 | $571 | $52 |
| Divalproex Sodium Er | None | 14 | $471 | $34 |
| Divalproex | None | 11 | $382 | $35 |
| Amitriptyline | None | 21 | $340 | $16 |
| Rizatriptan | None | 11 | $331 | $30 |
| Lamotrigine | None | 31 | $250 | $8 |
| Atorvastatin | None | 31 | $242 | $8 |
| Clopidogrel | None | 26 | $228 | $9 |
| Metoprolol | None | 21 | $130 | $6 |
| Donepezil | None | 15 | $114 | $8 |
| Cyclobenzaprine | None | 13 | $99 | $8 |
| Clonazepam | None | 18 | $80 | $4 |
2021: 4 drugs
| Tecfidera | 14 | $122,983 | $8,784 |
| Carbidopa-Levodopa | 12 | $561 | $47 |
| Levetiracetam | 12 | $409 | $34 |
| Propranolol | 12 | $230 | $19 |
2020: 5 drugs
| Memantine Hcl Er | 12 | $2,224 | $185 |
| Donepezil | 21 | $1,024 | $49 |
| Pyridostigmine | 11 | $584 | $53 |
| Levetiracetam | 18 | $552 | $31 |
| Prednisone | 12 | $42 | $4 |
2019: 13 drugs
| Tetrabenazine | 13 | $30,207 | $2,324 |
| Keppra | 12 | $7,015 | $585 |
| Namzaric | 12 | $5,909 | $492 |
| Memantine Hcl Er | 15 | $1,732 | $115 |
| Pyridostigmine | 18 | $841 | $47 |
| Levetiracetam | 37 | $528 | $14 |
| Donepezil | 26 | $373 | $14 |
| Clonazepam | 19 | $352 | $19 |
| Imipramine | 12 | $252 | $21 |
| Lamotrigine | 18 | $131 | $7 |
| Clopidogrel | 15 | $114 | $8 |
| Baclofen | 11 | $73 | $7 |
| Prednisone | 15 | $68 | $5 |
2018: 7 drugs
| Divalproex | 11 | $821 | $75 |
| Levetiracetam | 35 | $593 | $17 |
| Donepezil | 29 | $188 | $6 |
| Amitriptyline | 12 | $131 | $11 |
| Clonazepam | 14 | $95 | $7 |
| Baclofen | 13 | $76 | $6 |
| Prednisone | 12 | $35 | $3 |
Money from drug and device companies
$777 in 2024
| 2024 | 16 | 35 | None | $777 |
| 2023 | 20 | 50 | None | $1,048 |
| 2022 | 12 | 19 | None | $372 |
| 2021 | 4 | 5 | None | $115 |
| 2019 | 6 | 12 | None | $644 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Fintepla | $178 | 8 payments
|
| Lilly USA | Amyvid | $92 | 5 payments
|
| Argenx US | Vyvgart Hytrulo | $79 | 3 payments
|
| CSL Behring | Hizentra | $70 | 2 payments
|
| Abbvie | Botox | $68 | 3 payments
|
| Alexion Pharmaceuticals | Ultomiris | $46 | 2 payments
|
See all 35 published payments
| CSL Behring | Meals · 2024-07-18 | Hizentra | $35 |
| Ucb | Meals · 2024-07-18 | Fintepla | $38 |
| Alexion Pharmaceuticals | Meals · 2024-06-27 | Ultomiris | $26 |
| Banner Life Sciences | Meals · 2024-06-26 | Bafiertam | $23 |
| Novartis Pharmaceuticals | Meals · 2024-06-19 | Kesimpta | $15 |
| ACADIA Pharmaceuticals | Meals · 2024-06-13 | Nuplazid | $25 |
| Ucb | Meals · 2024-06-12 | Fintepla | $16 |
| Ucb | Meals · 2024-06-12 | Fintepla | $16 |
| Lilly USA | Meals · 2024-06-05 | Amyvid | $22 |
| Ucb | Meals · 2024-06-03 | Zilbrysq | $39 |
| Argenx US | Meals · 2024-06-01 | Vyvgart Hytrulo | $28 |
| Lilly USA | Meals · 2024-05-09 | Emgality | $14 |
| Abbvie | Meals · 2024-05-01 | Botox | $25 |
| Lilly USA | Meals · 2024-04-27 | Amyvid | $18 |
| Abbvie | Meals · 2024-04-24 | Qulipta | $27 |
| Neurocrine Biosciences | Meals · 2024-04-19 | Ingrezza | $27 |
| Argenx US | Meals · 2024-04-17 | Vyvgart Hytrulo | $21 |
| SK Life Science | Meals · 2024-03-20 | None | $19 |
| Ucb | Meals · 2024-03-15 | Fintepla | $33 |
| Lilly USA | Meals · 2024-03-13 | Amyvid | $14 |
| Lundbeck | Meals · 2024-03-11 | Vyepti | $20 |
| Alexion Pharmaceuticals | Meals · 2024-03-07 | Soliris | $20 |
| Argenx US | Meals · 2024-03-05 | Vyvgart Hytrulo | $30 |
| Abbvie | Meals · 2024-02-29 | Botox | $16 |
| CSL Behring | Meals · 2024-02-27 | Hizentra | $36 |
| EMD Serono | Meals · 2024-02-15 | None | $25 |
| Ucb | Meals · 2024-02-14 | Fintepla | $13 |
| Novartis Pharmaceuticals | Meals · 2024-02-13 | Kesimpta | $21 |
| Genentech USA | Meals · 2024-02-08 | Ocrevus | $21 |
| Ucb | Meals · 2024-02-05 | Rystiggo | $15 |
| Pfizer | Meals · 2024-02-01 | Nurtec Odt | $16 |
| Ucb | Meals · 2024-01-25 | Fintepla | $9 |
| Lilly USA | Meals · 2024-01-22 | Amyvid | $23 |
| Lundbeck | Meals · 2024-01-09 | Vyepti | $16 |
| Otsuka America Pharmaceutical | Meals · 2024-01-08 | Nuedexta | $16 |
See earlier years (2023, 2022, 2021, 2019)
2023: $1,048
| Abbvie | Ubrelvy | $225 | 12 payments
|
| Pfizer | Nurtec Odt | $110 | 6 payments
|
| Ucb | Fintepla | $92 | 4 payments
|
| Genentech USA | Ocrevus | $86 | 3 payments
|
| SK Life Science | None | $72 | 3 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $50 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $49 | 2 payments
|
| Amgen | Aimovig | $45 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $39 | 2 payments
|
| Lilly USA | Amyvid | $39 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $38 | 2 payments
|
| Kyowa Kirin | Nourianz | $36 | 2 payments
|
| Argenx US | Vyvgart | $28 | 1 payment
|
| Eisai | Fycompa | $25 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $25 | 1 payment
|
| Lundbeck | Vyepti | $21 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $20 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $17 | 1 payment
|
| Mitsubishi Tanabe Pharma America | Radicava | $16 | 1 payment
|
| TG Therapeutics | Briumvi | $16 | 1 payment
|
2022: $372
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $56 | 3 payments
|
| Abbvie | Ubrelvy | $47 | 2 payments
|
| Lilly USA | Emgality | $45 | 3 payments
|
| Novartis Pharmaceuticals | Kesimpta | $34 | 2 payments
|
| Amgen | Aimovig | $31 | 1 payment
|
| Neurelis | Valtoco | $30 | 1 payment
|
| Genzyme | Aubagio | $26 | 1 payment
|
| Eisai | Fycompa | $25 | 2 payments
|
| SK Life Science | None | $23 | 1 payment
|
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $21 | 1 payment
|
| Ucb | Fintepla | $18 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $16 | 1 payment
|
2021: $115
| Chiesi USA | Cleviprex | $46 | 1 payment
|
| Allergan | Botox | $35 | 2 payments
|
| Lilly USA | Emgality | $19 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $16 | 1 payment
|
2019: $644
| EMD Serono | Mavenclad | $292 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo | $123 | 2 payments
|
| Celgene | Ozanimod | $93 | 1 payment
|
| AbbVie | Duopa | $92 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $27 | 1 payment
|
| Acorda Therapeutics | Inbrija | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770036881
- Licence
- TX BP10056108Florida ME170254: ActiveTexas T2171: Active
- Group
- Upson Medical Associates LLC · St. Joseph Hospital of Nashua Nh
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 3102 4th St Apt W122, Lubbock, TX, 79415
- NPI first listed
- 2016-07-26
- NPI last updated
- 2024-12-12
- NPI record certified
- 2024-12-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3601 4th St Stop 8321, Lubbock, TX, 79430